CATEGORIES: Awareness | CMT Update

Disease Awareness Problem

by | Mar 23, 2017 | 2 comments

Charcot-Marie-Tooth Disease Awareness Problem from Hereditary Neuropathy Foundation on Vimeo.

If you walked up to a group of people in your town, your city, your school, or your neighborhood…and asked them if they ever heard about Multiple Sclerosis, the majority would say, “Yes.”

Now, ask them if they have ever heard of Charcot- Marie-Tooth…the majority would say “What?”

Even though the incidence of CMT is greater than that of MS and other diseases, CMT goes largely unrecognized–and not just among the general population. Patients go years without a proper diagnosis and care because many health care professionals (HCPs) are not aware of the disease or how to manage it.

Why are we still battling a disease awareness problem? This critical issue of disease was addressed in the closing keynote at the 2016 Patient-Centered Charcot-Marie- Tooth Summit. Robert Moore, husband to Allison Moore, CEO and Founder of HNF, led a compelling discussion on the challenges of CMT awareness and how we–as a community of patients, researchers, and HCPs– can give this disease the recognition it deserves. He encouraged us to keep pushing the boundaries of raising awareness within the CMT patient and HCP communities. Without awareness, we don’t have a voice.

You won’t want to miss this video of Robert, who not only educated but entertained the audience with his engaging keynote.

Learn more on this topic

Related Blog Posts

Double Your Donation

Corporate matching gift programs are charitable giving programs setup by corporations in which the company matches donations made by employees to eligible nonprofit organizations. For example, if a donor works for Bank of America and donates $100 to the Hereditary Neuropathy Foundation, Bank of America will double the donation by also writing a check for $100.

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Join the conversation

Leave a Comment

2 Comments

  1. Annette Weber

    Great presentation Rob-I learned so very much about the ordeal of this diagnosis.
    You made a great point of what we don’t know-we don’t think about and don’t try
    to understand. You were very informative about illness vey similar to CMT that
    we are all familiar with. I know your presentation inpacted my understanding and
    how to help—just spread the word about CMT and help make it a treatable illness
    that is commonly understood. Thank you Robert- this was a very personal and
    compassionate plea.

    Reply
  2. Danielle Zygmant

    There are many things we as a community are learning that we have in common, and I have had many doctors tell me things arent linked and they clearly are…its frustrating…my son has pectus carinatum as do I and so on, toe walking is a very big indicator too.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news